BJH - volume 8, issue Abstract Book BHS, february 2017
I. Moors MD, P. Vlummens MD, C. Lecluyse , J. Vermassen
BJH - volume 8, issue 1, february 2017
P. Vlummens MD
Multiple myeloma (MM) remains a devastating disease, even in the era of novel agents. As such, the search for new treatment modalities, alongside optimization of those already available, boldly continues. Each year, the ASH congress offers us the opportunity to learn about the latest developments in the MM field. This text aims to provide a brief summary of some of the latest insights presented at ASH this year.
(BELG J HEMATOL 2017;8(1):3–7)
Read moreBJH - volume 6, issue Abstract Book BHS, january 2015
V. Galle MD, C. De Vriendt , P. Vlummens MD, A. Vantilborgh , D. Benoit MD, PhD, E. De Coster
BJH - volume 6, issue Abstract Book BHS, january 2015
P. Vlummens MD, D. van de Putte , L. Libbrecht , L. Noens MD, PhD, V. Van Hende MD, T. Kerre MD, PhD
BJH - volume 6, issue Abstract Book BHS, january 2015
P. Vlummens MD, P. Gykiere , B. Lambert MD, E. Steel , T. Kerre MD, PhD
BJH - volume 5, issue Abstract Book BHS, january 2014
P. Vlummens MD, S. Bonte PhD, V. Van Hende MD, T. Kerre MD, PhD
Top
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
